Free. Unsubscribe any time.
VERTEX PHARMACEUTICALS INC / MA (VRTX)
VERTEX PHARMACEUTICALS INC / MA filed 74 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 14 reporting owners, covering 115 transactions and 377,869 shares. None carries the SEC's AFF10B5ONE flag; all 74 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-07-07, came on the same day as the one before it (2026-07-07) and reports 1 transaction against 1 in the filing before it.
- The sales it reports total 1,500 shares, 41 fewer than the 1,541 in the filing before it.
- Its 74 plan statements rank 1st of the 9 companies the register carries in Massachusetts, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 1 has more plan statements on file than it and 9 have fewer.
- Its 74 filings on file run from 2025-02-12 to 2026-07-07, and state no plan adoption date.
Trades in VERTEX PHARMACEUTICALS INC / MA 115
- Ambrose Kristen — 2025-02-11 · S · 1,376 shares
- Atkinson Edward Morrow III — 2025-02-11 · S · 1,747 shares
- Biller Jonathan — 2025-02-11 · S · 3,433 shares
- Tatsis Ourania — 2025-02-11 · S · 310 shares
- Ambrose Kristen — 2025-02-18 · S · 671 shares
- Biller Jonathan — 2025-02-18 · S · 1,657 shares
- Tatsis Ourania — 2025-02-18 · S · 244 shares
- ALTSHULER DAVID — 2025-02-20 · S · 1,111 shares
- ALTSHULER DAVID — 2025-02-25 · S · 848 shares
- Ambrose Kristen — 2025-02-25 · S · 884 shares
- Atkinson Edward Morrow III — 2025-02-25 · S · 1,767 shares
- Tatsis Ourania — 2025-02-25 · S · 354 shares
Adoption dates in VERTEX PHARMACEUTICALS INC / MA 0
Results prints in VERTEX PHARMACEUTICALS INC / MA 7
- 2025-02-10
- 2025-05-05
- 2025-08-04
- 2025-11-03
- 2026-02-12
- 2026-05-04
- 2026-08-03
Trades before a print in VERTEX PHARMACEUTICALS INC / MA 7
- 0 days before the 2026-05-04 print — 2026-05-04 · S · Bhatia Sangeeta N. · 318 shares
- 1 day before the 2026-02-12 print — 2026-02-11 · S · Ambrose Kristen · 1,376 shares
- 1 day before the 2026-02-12 print — 2026-02-11 · S · Biller Jonathan · 1,925 shares
- 1 day before the 2026-02-12 print — 2026-02-11 · S · Bunnage Mark E. · 2,021 shares
- 1 day before the 2026-02-12 print — 2026-02-11 · S · Tatsis Ourania · 466 shares
- 3 days before the 2025-05-05 print — 2025-05-02 · S · Bhatia Sangeeta N. · 400 shares
- 3 days before the 2026-05-04 print — 2026-05-01 · S · Liu Joy · 1,104 shares
- 32 days before the 2025-11-03 print — 2025-10-02 · S · Biller Jonathan · 694 shares
- 32 days before the 2026-08-03 print — 2026-07-02 · S · McKechnie Duncan · 1,541 shares
- 32 days before the 2026-08-03 print — 2026-07-02 · S · Tatsis Ourania · 1,500 shares
- 33 days before the 2026-05-04 print — 2026-04-01 · S · Liu Joy · 978 shares
- 33 days before the 2026-08-03 print — 2026-07-01 · S · Liu Joy · 828 shares
Interval to VERTEX PHARMACEUTICALS INC / MA’s next reported results date
How the interval and sources are counted →
- 7within 5 days
- 7within 10 days
- 0shortest, days
- 0no later print
- Bhatia Sangeeta N. 2025-05-02 · S · 3 days before the 2025-05-05 print
- Ambrose Kristen 2026-02-11 · S · 1 day before the 2026-02-12 print · SVP & Chief Accounting Officer
- Biller Jonathan 2026-02-11 · S · 1 day before the 2026-02-12 print · EVP and Chief Legal Officer
- Bunnage Mark E. 2026-02-11 · S · 1 day before the 2026-02-12 print · EVP, Chief Scientific Officer
- Tatsis Ourania 2026-02-11 · S · 1 day before the 2026-02-12 print · EVP, Chief Reg. & Quality Off.
- Liu Joy 2026-05-01 · S · 3 days before the 2026-05-04 print · EVP and Chief Legal Officer
- Bhatia Sangeeta N. 2026-05-04 · S · 0 days before the 2026-05-04 print
Reported results dates on file
- 2025-02-10
- 2025-05-05
- 2025-08-04
- 2025-11-03
- 2026-02-12
- 2026-05-04
- 2026-08-03
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- ARROWHEAD PHARMACEUTICALS, INC. 23
- GILEAD SCIENCES, INC. 65
Sources: SEC EDGAR full-text search and the SEC submissions API.